Back
Inhibrx Vs. Intra-Cellular Therapies Industry Stock Comparison
Buy
68
INBX
Inhibrx
Last Price:
34.34
Seasonality Move:
24.75%
Sell
38
ITCI
Intra-Cellular Therapies
Last Price:
65.54
Seasonality Move:
-6.93%
Buy
68
Inhibrx (INBX)
is a Buy
Is Inhibrx a Buy, Sell or Hold?
- The current Inhibrx [INBX] share price is $34.46. The Score for INBX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- INBX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $65.32. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INBX Stock Price Chart
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $65.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.
INBX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 49.74 | Sell |
Chaikin Money Flow: | -300465 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.1 - 34.52) | Buy |
Bollinger Bands (100): | (34.15 - 37.31) | Sell |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.32 | Sell |
Relative Strength Index (14 RSI): | 41.48 | Sell |
Chaikin Money Flow: | 421582 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.45 - 74.29) | Sell |
Bollinger Bands (100): | (65.99 - 72.19) | Sell |
INBX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.4 | Buy |
20-day SMA: | 34.28 | Buy |
50-day SMA: | 34.64 | Sell |
200-day SMA: | 27.94 | Buy |
8-day EMA: | 34.42 | Buy |
20-day EMA: | 34.41 | Buy |
50-day EMA: | 34.57 | Sell |
200-day EMA: | 30.47 | Buy |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.78 | Sell |
20-day SMA: | 69.19 | Sell |
50-day SMA: | 68.67 | Sell |
200-day SMA: | 62.8 | Buy |
8-day EMA: | 66.34 | Sell |
20-day EMA: | 68 | Sell |
50-day EMA: | 68.71 | Sell |
200-day EMA: | 64.66 | Buy |
Inhibrx Earnings Growth & INBX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.49 per share, a decrease next quarter of $0.08 per share, a decrease this year of $1.44 per share, and an increase next year of $0.91 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.
Inhibrx Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |